Home » Archive

Articles tagged with: Prevention

Featured, Public Health, Science, Society »

Pre-exposure Prophylaxis (PrEP): not such a good idea?

Just before “Treatment as Prevention” hit the headlines with some controversy, PrEP or Pre Exposure Prophylaxis, was on everybody’s lips.

PrEP is an experimental approach that would use antiretroviral medications (ARVs, which are normally used to treat people living with HIV) to reduce the risk of HIV infection in HIV-negative people. In this intervention, HIV-negative people would take a single drug or a combination of drugs with the hope that it would lower their risk of infection if exposed to HIV. PrEP trials are ongoing around the world. (Source: AVAC)

Whilst some …

Economics, Featured, Public Health, Science »

Treatment as Prevention: The Agony and the Ecstasy

Treatment as a means to prevent HIV infection has hit the media following a declaration by Brian Williams, professor of epidemiology at the South African Centre for Epidemiological Modelling and Analysis in Stellenbosch, at the AAAS in San Diego.
Whilst the HIV epidemic has shown some signs of stabilisation in the recent years, more than 7,000 people are still infected every day with the virus that causes AIDS.
Despite interesting results of a vaccine trial in Thailand, prevention is still limited to a small number of options many of which are not …

Featured, Society »

Glam for guiltless giving

The MAC AIDS Funds (MAF) new campaign to raise awareness and funding for HIV-AIDS research brings together two glam artists, Lady Gaga and Cyndi Lauper. This women’s initiative aimed at strengthening the service network and resources available to women living with and at risk of contracting HIV.
The two artists will promote the sale of limited editions of lipsticks created to support the work of the funds.
Unlike Starbuck armchair’s activism, where less than 10% of what you spend on expensive lattes goes to support HIV/AIDS programmes, M-A-C decided that every cent …

Public Health, Science, Technology »

HIV Prevention Clinical Trials: Size Matters

In February 2009 the Microbicide Trial Network (MTN) announced the main finding of its Phase II/IIb Safety and Effectiveness Study of the Vaginal Microbicides 0.5% PRO 2000 Gel for the Prevention of HIV Infection in Women (a.k.a HPTN 035).
This study conducted in Africa and the US was set up to find out if a chemical compound called PRO 2000 could prevent HIV infection in women. The compound itself came as a gel that women needed to apply vaginally prior to have sex. The concept of a product that can be …